Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,209 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06067399Recruiting
Red blood cell width and blood sugar in type 2 diabetes
This study looks at two blood test results—HbA1c (average blood sugar) and red blood cell width (RDW)—in people with type 2 diabetes whose blood sugar is not well controlled. The goal is to see how these two measurements relate after improving blood sugar management.
Al KhārjahAges 40 years+ - NCT07032844Recruiting
Better diabetes care for people with physical disabilities using telehealth
This trial tests if telehealth support through your primary care doctor can help you manage type 2 diabetes and other health conditions. It focuses on people who have a physical disability and need help controlling their blood sugar.
Birmingham, AlabamaAges 18–89 - NCT06729996RecruitingPhase 2
Comparing two diabetes medicines for pancreatitis-related diabetes
This trial tests whether pioglitazone or empagliflozin is better at managing diabetes caused by chronic or recurrent pancreatitis. You will take one of these pills daily for 6 months and track your blood sugar and ketones at home. The goal is to find a safer, more effective treatment for this type of diabetes.
Rochester, MinnesotaAges 18–80 - NCT07732777Recruiting
AI-assisted insulin pump study for type 1 diabetes
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
Nanjing, JiangsuAges 14–65 - NCT07227805Recruiting
Study of a new automated insulin system for diabetes
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
AntwerpAges 2 years+ - NCT07532863Recruiting
Heart Health Study for Newly Diagnosed Type 2 Diabetes
This study looks at how newly diagnosed type 2 diabetes affects heart and blood vessel health. Researchers will follow patients over time to understand the relationship between diabetes and cardiovascular risk.
Tangerang, BantenAges 40–70 - NCT07674628Recruiting
Coping skills program for Hispanic/Latinx military patients with diabetes
This study tests a program to help Hispanic/Latinx military patients with type 2 diabetes learn healthier ways to cope with stress and manage their diabetes. It may help you improve your blood sugar control and daily self-care.
San Antonio, TexasAges 18–70 - NCT07156370Recruiting
Saliva cortisol test for hard-to-control diabetes
This study checks if a simple saliva test can find high cortisol levels in people with hard-to-control type 2 diabetes. It aims to help doctors identify if cortisol problems are making diabetes worse.
ShanghaiAges 18–80 - NCT07724340RecruitingPhase 2
Study of AT673 plus semaglutide for type 2 diabetes and weight loss
This study tests a new medication called AT673 combined with semaglutide (Wegovy) to help people with type 2 diabetes and overweight or obesity lose weight and improve blood sugar. It is for people who have tried diet and exercise to lose weight but haven't had success.
Chandler, ArizonaAges 18 years+ - NCT06630182Recruiting
Does personality affect diabetic foot wound healing?
This study looks at how your feelings and personality might affect the healing of a diabetic foot wound. Researchers will ask you to complete questionnaires about your emotional state to see if there is a link to wound recovery.
DijonAges 18–18 - NCT06752369Recruiting
Online program for teens with type 1 diabetes and depression
This study tests a short online program to help teens with type 1 diabetes who feel down. It aims to see if a few sessions can improve mood and diabetes management.
Orlando, FloridaAges 12–17 - NCT07722910Recruiting
Iris blood flow in diabetic neovascular glaucoma
This study uses a special camera (OCTA) to look at blood flow in the iris of people with or without type 2 diabetes and diabetic neovascular glaucoma. The goal is to understand how blood flow changes in this eye condition.
Jinan, ShandongAges 18 years+ - NCT07465224RecruitingPhase 2
Study of ALN-4324 on Insulin Sensitivity in Type 2 Diabetes
This study tests an experimental drug, ALN-4324, to see if it can improve how your body responds to insulin. It’s for adults with type 2 diabetes who are already on certain diabetes medications and have stable blood sugar control.
Chula Vista, CaliforniaAges 18–65 - NCT05079399Recruiting
Diabetic eye screening study using eye scans
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
Carmel, IndianaAges 18 years+ - NCT07719894RecruitingPhase 4
Preventing heart problems in type 2 diabetes with cilostazol and aspirin
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07548996RecruitingPhase 2/Phase 3
Study of oral dimethyl fumarate for type 1 diabetes
This study tests an oral capsule called dimethyl fumarate to see if it can help preserve the body’s own insulin production in adults with type 1 diabetes. It may offer a way to slow the loss of beta cells and reduce reliance on insulin.
Nanjing, JiangsuAges 18–65 - NCT06497595Recruiting
Lifestyle program to prevent muscle loss in older adults with diabetes on semaglutide
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
Jerusalem, IsraelAges 65 years+ - NCT07717424Recruiting
Quality of life and emotions in gestational diabetes
This study looks at how gestational diabetes affects your quality of life and emotional well-being. By answering a few questions, it aims to better understand and support women like you.
Ludhiana, PunjabAges 20–40 - NCT07061652Recruiting
Support program for caregivers of patients with cancer and diabetes
This study supports family members or friends who care for someone with both cancer and diabetes. It tests a program to help caregivers manage their own stress and health while supporting their loved one.
Tampa, FloridaAges 18–99 - NCT07270731RecruitingPhase 1
Study of a new medicine for type 2 diabetes and healthy volunteers
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
NeussAges 18–64 - NCT07712913RecruitingPhase 3
Pregabalin for nerve pain from diabetes or shingles
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
Salvador, Estado de BahiaAges 18–75 - NCT07149142Recruiting
AI eye screening for children with type 1 diabetes
This study tests if an artificial intelligence (AI) system can effectively screen for eye problems related to diabetes (retinopathy) in children. The goal is to find a faster, easier way to protect your child's vision.
Prague, Prague 5Ages 11–19 - NCT05188014Recruiting
Exercise timing your menstrual cycle in type 1 diabetes
This study looks at how doing exercise at different points in your menstrual cycle affects blood sugar control in people with type 1 diabetes. It may help you and your care team understand how to plan exercise more safely and effectively around your period.
Edmonton, AlbertaAges 18–50 - NCT07711171RecruitingPhase 4
Canagliflozin for type 2 diabetes with mild memory problems
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
Shanghai, Shanghai MunicipalityAges 40–75
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,209 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.